$2.83
9.46% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US13173L1070
Symbol
CBUS

Calyxt, Inc. Stock price

$2.83
+1.03 56.94% 1M
-1.15 28.84% 6M
+0.05 1.62% YTD
-14.95 84.10% 1Y
-12.68 81.78% 3Y
-227.18 98.77% 5Y
-559.68 99.50% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.30 9.46%
ISIN
US13173L1070
Symbol
CBUS
Sector
Industry

Key metrics

Market capitalization $92.30m
Enterprise Value $315.85m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 66.49
P/S ratio (TTM) P/S ratio 19.43
P/B ratio (TTM) P/B ratio 1.31
Revenue growth (TTM) Revenue growth 104.78%
Revenue (TTM) Revenue $4.75m
EBIT (operating result TTM) EBIT $-79.13m
Free Cash Flow (TTM) Free Cash Flow $-57.26m
Cash position $23.59m
EPS (TTM) EPS $-10.93
P/S forward 16.78
EV/Sales forward 57.43
Short interest 9.92%
Show more

Is Calyxt, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Calyxt, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Calyxt, Inc. forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a Calyxt, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Calyxt, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4.75 4.75
105% 105%
100%
- Direct Costs 6.65 6.65
11% 11%
140%
-1.89 -1.89
49% 49%
-40%
- Selling and Administrative Expenses 20 20
6% 6%
429%
- Research and Development Expense 50 50
4% 4%
1,057%
-72 -72
6% 6%
-1,526%
- Depreciation and Amortization 6.65 6.65
11% 11%
140%
EBIT (Operating Income) EBIT -79 -79
5% 5%
-1,666%
Net Profit -275 -275
4% 4%
-5,786%

In millions USD.

Don't miss a Thing! We will send you all news about Calyxt, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Calyxt, Inc. Stock News

Neutral
GlobeNewsWire
one day ago
SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will host a presentation at the AGP Annual Virtu...
Neutral
Seeking Alpha
10 days ago
Cibus, Inc. (NASDAQ:CBUS ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Carlo Broos - Interim CFO Peter Beetham - Co-Founder, Interim CEO, President, COO & Director Gregory Gocal - Co-Founder, Chief Scientific Officer & EVP Conference Call Participants Laurence Alexander - Jefferies Austin Moeller - Canaccord Sameer Joshi - H.C. Wainwright Matthew Venezia - AGP O...
Neutral
GlobeNewsWire
12 days ago
Rice business momentum builds with Cibus' first stacked gene edited herbicide tolerance traits, which the Company believes is an industry first; On track for 2027 targeted commercial launch of HT1 and HT3 traits with customer germplasm integration underway across multiple markets Positive regulatory decision for Cibus' Rice traits HT1 and HT3 in Ecuador; the Ministry of Agriculture a nd Livesto...
More Calyxt, Inc. News

Company Profile

Calyxt, Inc. is technology company, which engages in delivering plant-based solutions. Its products include high oleic soybean oil, high fiber wheat, high oleic soybean meal, and low lignin alfalfa. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010 and is headquartered in Roseville, MN.

Head office United States
CEO Peter Beetham
Employees 159
Founded 2001
Website www.cibus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today